126 related articles for article (PubMed ID: 35896862)
1. Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for Neuroblastoma.
Kacsoh DB; Patel DN; Hsiang M; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Mol Neurosci; 2022 Sep; 72(9):2011-2019. PubMed ID: 35896862
[TBL] [Abstract][Full Text] [Related]
2. Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells.
Gozlan EC; Chobrutskiy BI; Zaman S; Yeagley M; Blanck G
J Mol Neurosci; 2021 Nov; 71(11):2393-2404. PubMed ID: 33666857
[TBL] [Abstract][Full Text] [Related]
3. Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma.
Kacsoh DB; Diaz MJ; Gozlan EC; Sahoo A; Song JJ; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12047-12056. PubMed ID: 37421457
[TBL] [Abstract][Full Text] [Related]
4. Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilities.
Agnila DRL; Huda TI; Eakins RA; Patel DN; Hsiang M; Chobrutskiy A; Chobrutskiy BI; Blanck G
Melanoma Res; 2023 Aug; 33(4):275-282. PubMed ID: 37222076
[TBL] [Abstract][Full Text] [Related]
5. IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities.
Charkowick SV; Huda TI; Patel DN; Yeagley M; Arturo JF; Cios KJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
Biochem Genet; 2024 Feb; 62(1):530-546. PubMed ID: 37392243
[TBL] [Abstract][Full Text] [Related]
6. Specific TCR V-J gene segment recombinations leading to the identification pan-V-J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma.
Cios KJ; Huda TI; Eakins RA; Mihyu MM; Blanck G
Leuk Lymphoma; 2022 Jun; 63(6):1314-1322. PubMed ID: 35019822
[TBL] [Abstract][Full Text] [Related]
7. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Tu YN; Tong WL; Callahan BM; Chobrutskiy BI; Blanck G
Anticancer Res; 2020 Apr; 40(4):2043-2051. PubMed ID: 32234895
[TBL] [Abstract][Full Text] [Related]
8. Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
Huda TI; Diaz MJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Alzheimers Dis; 2022; 88(2):619-629. PubMed ID: 35662120
[TBL] [Abstract][Full Text] [Related]
9. Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens.
Tu YN; Tong WL; Fawcett TJ; Blanck G
Lab Invest; 2017 Dec; 97(12):1516-1520. PubMed ID: 28805806
[TBL] [Abstract][Full Text] [Related]
10. A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
Patel DN; Yeagley M; Arturo JF; Falasiri S; Chobrutskiy BI; Gozlan EC; Blanck G
Int J Immunogenet; 2021 Oct; 48(5):409-418. PubMed ID: 34298587
[TBL] [Abstract][Full Text] [Related]
11. Lack of allelic exclusion by secondary rearrangements of tumour B-cell receptor light chains in hairy cell leukaemia.
Sozzi E; Amato T; Sahota SS; Nuti S; Raspadori D; Sicuranza A; Cencini E; Tosi P; Lauria F; Forconi F
Hematol Oncol; 2011 Mar; 29(1):31-7. PubMed ID: 20658474
[TBL] [Abstract][Full Text] [Related]
12. Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
Yeagley M; Chobrutskiy BI; Gozlan EC; Medikonda N; Patel DN; Falasiri S; Callahan BM; Huda T; Blanck G
Pediatr Hematol Oncol; 2021 Apr; 38(3):251-264. PubMed ID: 33616477
[TBL] [Abstract][Full Text] [Related]
13. CNV assessments associated with outcome distinctions for adult and pediatric cancers: Loss of BRCA1 in neuroblastoma associates with a lower survival probability.
Varkhedi M; Barker VR; Eakins RA; Blanck G
Gene; 2022 Aug; 836():146673. PubMed ID: 35714795
[TBL] [Abstract][Full Text] [Related]
14. Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.
Pakasticali N; Chobrutskiy A; Patel DN; Hsiang M; Zaman S; Cios KJ; Blanck G; Chobrutskiy BI
Cancer Inform; 2023; 22():11769351231177269. PubMed ID: 37313373
[TBL] [Abstract][Full Text] [Related]
15. Development and application of a next-generation sequencing protocol and bioinformatics pipeline for the comprehensive analysis of the canine immunoglobulin repertoire.
Cullen JN; Martin J; Vilella AJ; Treeful A; Sargan D; Bradley A; Friedenberg SG
PLoS One; 2022; 17(7):e0270710. PubMed ID: 35802654
[TBL] [Abstract][Full Text] [Related]
16. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the molecular characteristics of the tumor-immune interaction and the development of an individualized immune prognostic signature for neuroblastoma.
Jin W; Zhang Y; Liu Z; Che Z; Gao M; Peng H
J Cell Physiol; 2021 Jan; 236(1):294-308. PubMed ID: 32510620
[TBL] [Abstract][Full Text] [Related]
18. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
[TBL] [Abstract][Full Text] [Related]
19. An in vivo method for diversifying the functions of therapeutic antibodies.
Tian M; Cheng HL; Kimble MT; McGovern K; Waddicor P; Chen Y; Cantor E; Qiu M; Tuchel ME; Dao M; Alt FW
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33658386
[TBL] [Abstract][Full Text] [Related]
20. Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis.
Zaman S; Chobrutskiy BI; Patel JS; Diviney A; Tu YN; Tong WL; Gill T; Blanck G
Viral Immunol; 2020 Jun; 33(5):404-412. PubMed ID: 32315578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]